Rheumnow Podcast

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including on where you should sit in clinic and why you should worry about secondary Sjogrens in RA.

Dr. Jack Cush reviews the news and journal reports from the past week - including a few contrary reports on infection, seropositivity and plasmapheresis.

Exploring topics such as infections in patients on biologics, H. pylori infection and GI complications, IL-17 inhibitors and lupus management, vaccinations in rheumatology, and the impact of depression on all-cause mortality in RA patients.

Explore FDA approvals for interchangeable biosimilars and the impact of biologics on Still's disease. Learn about the connection between obstructive sleep apnea and gout, post-SARS-CoV-2 infection risks, and diagnostic utility of MRI in myositis cases. Dive into the role of anti-synthetase antibodies, depression risk in RA patients, and arthritis prevalence in the US.

Dive into the 2023 EULAR recommendations for treating lupus with a focus on personalized care and reducing glucocorticoid use. Learn about medication selection considerations, balancing steroids, and overcoming adherence challenges in lupus care.

Explore the relationship between weather and musculoskeletal symptoms, the importance of strength in preventing falls and fractures, risks for joint issues in inflammatory bowel disease patients, innovations in biosimilars and monoclonal antibodies, and pregnancy outcomes in rheumatoid arthritis mothers

Exploring immunosuppression, prevalence, and its implications. Highlights include recent autoimmune disease research on inflammatory arthritis referrals, myositis diagnosis, lupus nephritis outcomes, infections in lupus patients, and advancements in treatment for autoimmune diseases like psoriasis and RA.

Dr. Jack Cush and guests discuss complex rheumatology cases including RA with TB, relapsing polychondritis, ICI induced RA in breast cancer, sarcoidosis in the maxilla, and acute onset monoarthritis in a young woman. They explore unique treatment approaches, challenges, and diagnostic strategies for these rare cases.

Dr. Jack Cush discusses the use of steroids in autoimmune diseases, disease activity in RA patients, telemedicine impact, fracture risk in CPPD disease, cancer risk in RA and AS patients, gout flare treatment with urea-lowering therapy, autoimmune disease prevention post VITAL trial, and skepticism towards vitamin D and omega-3 supplementation.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week we discuss hipsters undergoing hip replacement, pregnancy outcomes in RA and the future of academic clinicians.